We are proud to announce that our Co-Founder and CEO, Tim Keane has been selected as a finalist to present at the RESI JPM 2025 Innovator Pitch Challenge during the upcoming JP Morgan Healthcare Conference (January 13–16, 2025). TYBR Health is optimizing post-operative recovery with our innovative B3 Gel—a natural, easy-to-apply barrier designed to protect tendons and ligaments during healing. If you’ll be at JPM and are interested in connecting to learn more, let us know! #innovation #healthcareinvestors #B3GEL #RESIJPM
TYBR Health is a finalist in the Innovator’s Pitch Challenge at RESI JPM! 🌟 Tim Keane will present their innovation to a panel of early-stage investors on Tuesday, January 14, at the San Francisco Marriott Marquis. The IPC is a unique platform where founders and CEOs connect directly with investors, gaining actionable feedback and extra exposure at RESI. Spots are filled, but you can still experience the energy of RESI JPM—join us to connect with top-tier innovators and investors. Register today: https://lnkd.in/eMWxaEeu #RESI #RESIJPM #LifeScience #Healthcare #Innovation